Zim Labs gets regulatory nod in Portugal for multiple sclerosis treatment drug Dimethyl Fumarate |
Zim Laboratories Ltd - Zim Laboratories Limited - Updates |
Zim Laboratories Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
Zim Laboratories Ltd - Zim Laboratories Limited - Acquisition |
Zim Laboratories Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Zim Laboratories Ltd - Zim Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
Zim Laboratories Ltd - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
Zim Laboratories Ltd - Zim Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
Zim Laboratories Ltd - Zim Laboratories Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
Zim Laboratories consolidated net profit declines 16.32% in the December 2024 quarter |